Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 837

Results For "AI"

8746 News Found

Marksons Pharma PAT at Rs 62.6 cr. for Q1FY22
News | August 11, 2021

Marksons Pharma PAT at Rs 62.6 cr. for Q1FY22

The company has tied up with OrbiMed as a financial partner for global reach


Lupin posts net profit of Rs 542.46 cr. in Q1FY22
News | August 11, 2021

Lupin posts net profit of Rs 542.46 cr. in Q1FY22

The profits were bolstered by the Boehringer Ingelheim MEK program income


Sequent Scientific net profit at Rs 87.30 lakh in Q1FY22
News | August 11, 2021

Sequent Scientific net profit at Rs 87.30 lakh in Q1FY22

Formulation business grew by 15 per cent in the quarter


Krishna Institute of Medical Sciences PAT at Rs 89.12 cr for Q1FY22
News | August 11, 2021

Krishna Institute of Medical Sciences PAT at Rs 89.12 cr for Q1FY22

KIMS Hospitals' brand, has an aggregate bed capacity of 3,064, including over 2,500 operational beds as of March 31, 2021


NPPA has put a cap on the trade margin of 42 select non-scheduled anti-cancer medicines
Policy | August 11, 2021

NPPA has put a cap on the trade margin of 42 select non-scheduled anti-cancer medicines

A total of 526 brands has seen a reduction of up to 90 per cent in MRP


NRx Pharmaceuticals announces initiation of Phase 2b trial of BriLife vaccine for Covid-19
Drug Approval | August 10, 2021

NRx Pharmaceuticals announces initiation of Phase 2b trial of BriLife vaccine for Covid-19

Preclinical and early human data indicate BriLife may confer enhanced immunity against Delta variant


SMS Pharmaceuticals revenue grows by 44%; Profit up 235%
News | August 10, 2021

SMS Pharmaceuticals revenue grows by 44%; Profit up 235%

This robust performance is a testimony of the company's agility, resilience and strong execution capabilities during these difficult times


Bayer strengthens drug discovery platform through acquisition of Vividion Therapeutics
Biotech | August 10, 2021

Bayer strengthens drug discovery platform through acquisition of Vividion Therapeutics

Purchase price of US $ 1.5 billion upfront and up to USD 500 million in success-based milestone payments


Merck launches New Pergoveris Pen for fertility treatment in India
Healthcare | August 10, 2021

Merck launches New Pergoveris Pen for fertility treatment in India

A globally approved pen filled by mass technology provides a safer self- administration fertility solution


Hinduja Global Solutions sells its healthcare services to Barings for US $ 1.2 billion
Digitisation | August 10, 2021

Hinduja Global Solutions sells its healthcare services to Barings for US $ 1.2 billion

The healthcare vertical is US-focused, has 35-plus clients and 24,000 employees across 34 locations in five countries